These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6133838)

  • 1. Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
    Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):135-42. PubMed ID: 6133838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.
    Aellig WH; Nüesch E
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):106-12. PubMed ID: 403149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergotamine and dihydroergotamine enhance guanylate cyclase activity.
    Vesely DL
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):245-54. PubMed ID: 6136069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
    Looper ML; Edrington TS; Moubarak AS; Callaway TR; Rosenkrans CF
    Foodborne Pathog Dis; 2008 Oct; 5(5):599-604. PubMed ID: 18681792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific radioimmunoassay of ergot peptide alkaloids in plasma.
    Schran HF; Schwarz HJ; Talbot KC; Loeffler LJ
    Clin Chem; 1979 Nov; 25(11):1928-33. PubMed ID: 498503
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics].
    Mercier C
    J Pharm Belg; 1982; 37(4):289-98. PubMed ID: 6754905
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E
    Gen Pharmacol; 1983; 14(1):95-102. PubMed ID: 6826043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ergot alkaloids. XXII. Separation of mixtures of the levorotatory alkaloids of the ergotamine and ergotoxine group by countercurrent distribution].
    BERAN M; SEMONSKY M
    Cesk Farm; 1962 Nov; 11():440-51. PubMed ID: 13967596
    [No Abstract]   [Full Text] [Related]  

  • 11. Degradation and epimerization of ergot alkaloids after baking and in vitro digestion.
    Merkel S; Dib B; Maul R; Köppen R; Koch M; Nehls I
    Anal Bioanal Chem; 2012 Nov; 404(8):2489-97. PubMed ID: 22968686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of ergot alkaloids in clinical use.
    Berde B
    Med J Aust; 1978 Nov; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract]   [Full Text] [Related]  

  • 13. Analytical studies on ergot alkaloids and their derivatives. I. Separation of ergot alkaloids of the ergotoxine and ergotamine groups by thin-layer chromatography.
    Reichelt J; Kudrnác S
    J Chromatogr; 1973 Dec; 87(2):433-6. PubMed ID: 4358218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prophylactic treatment of episodic forms of cluster headache].
    Liaño H; López-Zuazo I
    Rev Neurol; 1995; 23 Suppl 4():S525-9. PubMed ID: 8556661
    [No Abstract]   [Full Text] [Related]  

  • 15. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of ergot alkaloids in biological fluids by radioimmunoassay.
    Kleimola TT
    Br J Clin Pharmacol; 1978 Sep; 6(3):255-60. PubMed ID: 687503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic metabolism of ergot alkaloids in beef cattle by cytochrome P450.
    Moubarak AS; Rosenkrans CF
    Biochem Biophys Res Commun; 2000 Aug; 274(3):746-9. PubMed ID: 10924348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromatographic determination of ergotamine and ergotoxine].
    KOSTIR JV; RYBAR DJ; OULEHLA B; HAIS IM; BERAN M
    Cesk Farm; 1952; 1(11-12):621-5. PubMed ID: 13032999
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric secretagogue action of ergot alkaloids in the perfused stomach of anesthetized rats.
    Maeda-Hagiwara M; Watanabe K
    Eur J Pharmacol; 1982 Apr; 79(1-2):105-10. PubMed ID: 7084301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of dihydroergotamine in healthy volunteers and in neurological patients after a single intravenous injection.
    Kanto J; Allonen H; Koski K; Koulu M; Lammintausta R; Mäntylä R; Kleimola T; Siirtola T
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):127-30. PubMed ID: 7228454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.